Compounds > valproic acid

valproic acid and everolimus

valproic acid has been researched along with everolimus in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Blaheta, RA; Haferkamp, A; Hudak, L; Juengel, E; Seibel, JM; Tsaur, I; Wedel, S; Wiesner, C1
Blaheta, RA; Haferkamp, A; Hudak, L; Juengel, E; Makarević, J; Seibel, JM; Tsaur, I; Wedel, S; Wiesner, C1
Blaheta, RA; Haferkamp, A; Hudak, L; Juengel, E; Makarević, J; Seibel, JM; Tsaur, I; Waaga-Gasser, A; Wedel, S1
Bartsch, G; Blaheta, RA; Dauselt, A; Haferkamp, A; Juengel, E; Makarević, J; Tsaur, I; Wiesner, C1
Bartsch, G; Blaheta, RA; Haferkamp, A; Harder, S; Juengel, E; Makarevi, J; Mani, J; Natsheh, I; Nelson, K; Nowaz, S; Reiter, M; Tsaur, I; Werner, I1
Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T1
Schubert-Bast, S; Strzelczyk, A1

Reviews

3 review(s) available for valproic acid and everolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
    Epileptic disorders : international epilepsy journal with videotape, 2022, 12-01, Volume: 24, Issue:6

    Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide

2022
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
    CNS drugs, 2022, Volume: 36, Issue:10

    Topics: Autism Spectrum Disorder; Bromides; Cannabidiol; Clobazam; Cognition; Ethosuximide; Everolimus; Felbamate; Fenfluramine; Humans; Lacosamide; Lamotrigine; Levetiracetam; Pregabalin; Spasms, Infantile; Sulfides; Topiramate; Valproic Acid; Vigabatrin; Zinc Compounds; Zonisamide

2022

Other Studies

5 other study(ies) available for valproic acid and everolimus

ArticleYear
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001.
    Life sciences, 2011, Feb-28, Volume: 88, Issue:9-10

    Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Drug Therapy, Combination; ErbB Receptors; Everolimus; Flow Cytometry; Histone Deacetylase Inhibitors; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Valproic Acid

2011
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
    Clinical & experimental metastasis, 2011, Volume: 28, Issue:5

    Topics: Cell Adhesion; Cell Movement; Drug Therapy, Combination; Enzyme Inhibitors; Everolimus; Histone Deacetylases; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Sirolimus; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Valproic Acid

2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
    BMC cancer, 2011, Aug-25, Volume: 11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Everolimus; Human Umbilical Vein Endothelial Cells; Humans; Integrins; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Purines; Signal Transduction; Sirolimus; Valproic Acid

2011
Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells.
    Cancer letters, 2012, Nov-01, Volume: 324, Issue:1

    Topics: Acetylation; Apoptosis; Carcinoma, Renal Cell; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Everolimus; Histone Deacetylase Inhibitors; Histones; Humans; Kidney Neoplasms; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Sirolimus; TOR Serine-Threonine Kinases; Valproic Acid

2012
HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.
    Molecular cancer, 2014, Jun-16, Volume: 13

    Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cyclin A; Cyclin-Dependent Kinase 2; Drug Resistance, Neoplasm; Everolimus; G2 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Sirolimus; Valproic Acid

2014